Free tool
Healthcare stocks
We cover 714 companies in the Healthcare sector. The median market value in the group is $446.43M. Across the group, the median move over the past trading day is 0.00%. 50% of the 690 with a 200-day average trade above it. Price change over the past year runs from −41.8% to +119.8% across the middle 80 percent of the group, with a median of +6.3%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
714 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LILY34.SA | Eli Lilly and Company | $1.10T | Mega cap | +59.83% |
| LLY | Eli Lilly and Company | $1.06T | Mega cap | +62.80% |
| LLY.DE | Eli Lilly and Company | $1.05T | Mega cap | +65.95% |
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% |
| JNJB34.SA | Johnson & Johnson | $658.09B | Mega cap | +47.82% |
| JNJ.DE | Johnson & Johnson | $641.00B | Mega cap | +57.15% |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +29.36% |
| ABBV34.SA | AbbVie Inc. | $467.00B | Mega cap | +21.88% |
| 4AB.DE | AbbVie Inc. | $457.78B | Mega cap | +29.91% |
| RHO.DE | Roche Holding AG | $368.45B | Mega cap | +39.25% |
| N1VS34.SA | Novartis AG | $301.83B | Mega cap | +20.04% |
| NVS | Novartis AG | $299.44B | Mega cap | +27.93% |
| NOT.DE | Novartis AG | $294.64B | Mega cap | +28.48% |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +5.09% |
| A1ZN34.SA | AstraZeneca PLC | $258.63B | Mega cap | +0.13% |
| AZN.L | AstraZeneca PLC | $256.20B | Mega cap | +3.37% |
| AZN.ST | AstraZeneca PLC | $255.60B | Mega cap | +3.69% |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% |
| AMG.DE | Amgen Inc. | $238.01B | Mega cap | +57.84% |
| TN8.DE | Thermo Fisher Scientific Inc. | $232.14B | Mega cap | +28.91% |
| N1VO34.SA | Novo Nordisk A/S | $208.90B | Mega cap | −17.86% |
| NVO | Novo Nordisk A/S | $208.63B | Mega cap | −13.32% |
| NOVO-B.CO | Novo Nordisk A/S | $206.43B | Mega cap | −13.55% |
| NOV.DE | Novo Nordisk A/S | $206.12B | Mega cap | +12.94% |
| NVO.WA | Novo Nordisk A/S | $200.44B | Mega cap | −7.94% |
| GHRS | GH Research PLC | $1.99B | Small cap | +112.84% |
| PIII | P3 Health Partners Inc. | $1.98B | Small cap | +26.37% |
| PGNY | Progyny, Inc. | $1.98B | Small cap | +14.55% |
| S1RP34.SA | Sarepta Therapeutics, Inc. | $1.98B | Small cap | −12.20% |
| FLRY3.SA | Fleury S.A. | $1.97B | Small cap | +37.82% |
| TSHA | Taysha Gene Therapies, Inc. | $1.96B | Small cap | +102.69% |
| VIMIAN.ST | Vimian Group AB (publ) | $1.96B | Small cap | +14.54% |
| EMBLA.CO | Embla Medical hf. | $1.96B | Small cap | −5.97% |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +13.69% |
| GXE.DE | Lakefront Biotherapeutics NV | $1.92B | Small cap | −43.15% |
| ASTH | Astrana Health, Inc. | $1.92B | Small cap | +23.71% |
| LKFT | Lakefront Biotherapeutics NV | $1.91B | Small cap | −11.39% |
| SNDA | Sonida Senior Living, Inc. | $1.91B | Small cap | +51.53% |
| NTLA | Intellia Therapeutics, Inc. | $1.89B | Small cap | +15.50% |
| DMRA | Damora Therapeutics, Inc. | $1.89B | Small cap | +804.46% |
| SEPN | Septerna, Inc. | $1.88B | Small cap | +218.81% |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.87B | Small cap | −28.63% |
| NEU.AX | Neuren Pharmaceuticals Limited | $1.87B | Small cap | +7.57% |
| DRW8.DE | Drägerwerk AG & Co. KGaA | $1.86B | Small cap | +59.38% |
| SGRY | Surgery Partners, Inc. | $1.84B | Small cap | −38.48% |
| PSNL | Personalis, Inc. | $1.82B | Small cap | +257.32% |
| LMAT | LeMaitre Vascular, Inc. | $1.81B | Small cap | −16.20% |
| INSP | Inspire Medical Systems, Inc. | $1.79B | Small cap | −33.04% |
| ATT.ST | Attendo AB (publ) | $1.77B | Small cap | +80.96% |
| 4540.T | Tsumura & Co. | $1.77B | Small cap | +11.13% |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.77B | Small cap | +23.55% |
| ALVO-SDB.ST | Alvotech | $1.76B | Small cap | −39.34% |
| FTRE | Fortrea Holdings Inc. | $1.76B | Small cap | +105.20% |
| ALVO | Alvotech | $1.75B | Small cap | −38.85% |
| ANAB | AnaptysBio, Inc. | $1.73B | Small cap | +326.47% |
| ANIP | ANI Pharmaceuticals, Inc. | $1.71B | Small cap | −18.85% |
| MAZE | Maze Therapeutics, Inc. | $1.69B | Small cap | +113.27% |
| SIA.TO | Sienna Senior Living Inc. | $1.65B | Small cap | +25.96% |
| 7716.T | Nakanishi Inc. | $1.65B | Small cap | +51.84% |
| AVLN | Avalyn Pharma Inc. | $1.64B | Small cap | +25.60% |
| BCAX | Bicara Therapeutics Inc. | $1.64B | Small cap | +105.74% |
| AGL | agilon health, inc. | $1.61B | Small cap | +194.58% |
| 8129.T | Toho Holdings Co., Ltd. | $1.60B | Small cap | −24.88% |
| RDC.DE | Redcare Pharmacy NV | $1.60B | Small cap | −16.64% |
| PYC.AX | PYC Therapeutics Limited | $1.59B | Small cap | +75.78% |
| CLARI.PA | Clariane SE | $1.59B | Small cap | −11.31% |
| BONEX.ST | Bonesupport Holding AB (publ) | $1.59B | Small cap | −25.84% |
| ARDT | Ardent Health, Inc. | $1.58B | Small cap | −11.64% |
| XERS | Xeris Biopharma Holdings, Inc. | $1.58B | Small cap | +8.64% |
| ABSI | Absci Corporation | $1.58B | Small cap | +261.57% |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.58B | Small cap | +132.58% |
| AAPG | Ascentage Pharma Group Internat | $1.58B | Small cap | −59.18% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | $1.58B | Small cap | +298.89% |
| HCSG | Healthcare Services Group, Inc. | $1.57B | Small cap | +47.05% |
| 4DX.AX | 4DMedical Limited | $1.57B | Small cap | +538.60% |
| 8086.T | Nipro Corporation | $1.56B | Small cap | +3.46% |
| TYRA | Tyra Biosciences, Inc. | $1.56B | Small cap | +103.57% |
| KMTS | Kestra Medical Technologies, Ltd. | $1.56B | Small cap | +47.61% |
| LBRX | LB Pharmaceuticals Inc | $1.55B | Small cap | +178.41% |
| AVBP | ArriVent BioPharma, Inc. | $1.54B | Small cap | +62.10% |
| CNMD | CONMED Corporation | $1.53B | Small cap | −6.91% |
| DIA.WA | Diagnostyka S.A. | $1.53B | Small cap | −16.84% |
| INVA | Innoviva, Inc. | $1.53B | Small cap | +7.06% |
| OMCL | Omnicell, Inc. | $1.53B | Small cap | +0.66% |
| NVAX | Novavax, Inc. | $1.52B | Small cap | +21.50% |
| 4516.T | Nippon Shinyaku Co., Ltd. | $1.52B | Small cap | +18.39% |
| NOLA-B.ST | Nolato AB (publ) | $1.51B | Small cap | −4.79% |
| 6849.T | Nihon Kohden Corporation | $1.50B | Small cap | −6.90% |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% |
| SPTX | Seaport Therapeutics, Inc. | $1.49B | Small cap | +40.32% |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | $1.49B | Small cap | +74.45% |
| INNV | InnovAge Holding Corp. | $1.48B | Small cap | +178.79% |
| AKTS | Aktis Oncology, Inc. | $1.47B | Small cap | +18.35% |
| AZTA | Azenta, Inc. | $1.47B | Small cap | +11.16% |
| OMDA | Omada Health, Inc. | $1.47B | Small cap | +2.74% |
| PAHC | Phibro Animal Health Corporation | $1.46B | Small cap | +13.01% |
| SDGR | Schrödinger, Inc. | $1.46B | Small cap | −1.62% |
| ENOV | Enovis Corporation | $1.46B | Small cap | −18.60% |
| ATEC | Alphatec Holdings, Inc. | $1.45B | Small cap | −41.78% |
| ORIC | ORIC Pharmaceuticals, Inc. | $1.44B | Small cap | +35.58% |
| 4483.T | JMDC Inc. | $1.44B | Small cap | −15.45% |
| MGTX | MeiraGTx Holdings plc | $1.43B | Small cap | +100.54% |
| GDS.PA | Ramsay Générale de Santé SA | $1.41B | Small cap | +10.00% |
| IMTX | Immatics N.V. | $1.41B | Small cap | +74.63% |
| F9L.F | Joincare Pharmaceutical Group Industry Co.,Ltd. | $1.40B | Small cap | −48.02% |
| JBIO | Jade Biosciences, Inc. | $1.39B | Small cap | +168.30% |
| VITR.ST | Vitrolife AB (publ) | $1.39B | Small cap | −28.19% |
| DRTS | Alpha Tau Medical Ltd. | $1.38B | Small cap | +343.92% |
| 3148.T | Create SD Holdings Co., Ltd. | $1.38B | Small cap | +1.90% |
| 9627.T | Ain Holdings Inc. | $1.37B | Small cap | +3.62% |
| 3360.T | Ship Healthcare Holdings, Inc. | $1.35B | Small cap | +8.75% |
| NUTX | Nutex Health Inc. | $1.34B | Small cap | +118.22% |
| PNTG | The Pennant Group, Inc. | $1.34B | Small cap | +56.31% |
| UPR.L | Uniphar plc | $1.33B | Small cap | +4.55% |
| AORT | Artivion, Inc. | $1.33B | Small cap | −37.81% |
| AMN | AMN Healthcare Services, Inc. | $1.33B | Small cap | +70.26% |
| MLTX | MoonLake Immunotherapeutics | $1.32B | Small cap | −71.82% |
| REG.AX | Regis Healthcare Limited | $1.32B | Small cap | −20.56% |
| MNKD | MannKind Corporation | $1.32B | Small cap | −9.51% |
| CRON.TO | Cronos Group Inc. | $1.31B | Small cap | +39.83% |
| CRON | Cronos Group Inc. | $1.31B | Small cap | +38.67% |
| IART | Integra LifeSciences Holdings Corporation | $1.31B | Small cap | +13.52% |
| VOR | Vor Biopharma Inc. | $1.30B | Small cap | −40.82% |
| RYM.AX | RYM FPO NZX [RYM] | $1.29B | Small cap | −27.80% |
| SPI.L | Spire Healthcare Group plc | $1.28B | Small cap | +9.22% |
| 2175.T | SMS Co., Ltd. | $1.27B | Small cap | +58.30% |
| 4544.T | H.U. Group Holdings, Inc. | $1.25B | Small cap | +3.16% |
| SANA | Sana Biotechnology, Inc. | $1.25B | Small cap | +23.44% |
| GDRX | GoodRx Holdings, Inc. | $1.25B | Small cap | −18.89% |
| CERT | Certara, Inc. | $1.24B | Small cap | −25.07% |
| SNZ.AX | Summerset Group Holdings Limited | $1.24B | Small cap | −27.67% |
| BIOG-B.ST | BioGaia AB (publ) | $1.23B | Small cap | +14.57% |
| ODTX | Odyssey Therapeutics, Inc. | $1.23B | Small cap | +56.03% |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.23B | Small cap | +207.92% |
| CRVS | Corvus Pharmaceuticals, Inc. | $1.22B | Small cap | +167.82% |
| 4553.T | Towa Pharmaceutical Co., Ltd. | $1.21B | Small cap | +38.84% |
| PRCT | PROCEPT BioRobotics Corporation | $1.21B | Small cap | −48.36% |
| 2160.T | GNI Group Ltd. | $1.20B | Small cap | +8.51% |
| CVSG.L | CVS Group plc | $1.19B | Small cap | +5.94% |
| IVA.PA | Inventiva S.A. | $1.17B | Small cap | −13.48% |
| AVNS | Avanos Medical Inc | $1.17B | Small cap | +110.53% |
| USPH | U.S. Physical Therapy, Inc. | $1.17B | Small cap | −5.67% |
| 4887.T | Sawai Group Holdings Co., Ltd. | $1.17B | Small cap | −11.69% |
| KURA | Kura Oncology, Inc. | $1.16B | Small cap | +66.16% |
| SPH.WA | Sopharma AD | $1.15B | Small cap | −37.61% |
| TDOC | Teladoc Health, Inc. | $1.15B | Small cap | −18.22% |
| SVRA | Savara Inc. | $1.15B | Small cap | +70.52% |
| LMRI | Lumexa Imaging Holdings, Inc. | $1.15B | Small cap | −35.42% |
| STAA | STAAR Surgical Company | $1.15B | Small cap | −16.90% |
| TTALO.HE | Terveystalo Oyj | $1.14B | Small cap | −22.07% |
| IVA | Inventiva S.A. | $1.14B | Small cap | −7.84% |
| T2DH34.SA | Teladoc Health, Inc. | $1.13B | Small cap | −24.67% |
| 7476.T | AS ONE Corporation | $1.12B | Small cap | +2.25% |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | $1.12B | Small cap | +24.68% |
| IRMD | IRADIMED CORPORATION | $1.12B | Small cap | +19.80% |
| OPK | OPKO Health, Inc. | $1.11B | Small cap | +6.34% |
| AVTX | Avalo Therapeutics, Inc. | $1.10B | Small cap | +112.95% |
| PHIL.MI | Philogen S.p.A. | $1.09B | Small cap | +2.99% |
| 006280.KS | GC Biopharma Corp. | $1.09B | Small cap | +1.63% |
| J2AZ34.SA | Jazz Pharmaceuticals plc | $1.08B | Small cap | +35.66% |
| 069620.KS | Daewoong Pharmaceutical Co., Ltd | $1.08B | Small cap | −4.97% |
| 4547.T | Kissei Pharmaceutical Co., Ltd. | $1.07B | Small cap | −1.73% |
| GXI.DE | Gerresheimer AG | $1.05B | Small cap | −41.09% |
| SLDB | Solid Biosciences Inc. | $1.04B | Small cap | +72.95% |
| LXRX | Lexicon Pharmaceuticals, Inc. | $1.04B | Small cap | +104.42% |
| CSTL | Castle Biosciences, Inc. | $1.04B | Small cap | +52.96% |
| MEDCL.PA | MedinCell S.A. | $1.03B | Small cap | +43.09% |
| WVE | Wave Life Sciences, Inc. | $1.03B | Small cap | −48.12% |
| ABUS | Arbutus Biopharma Corporation | $1.03B | Small cap | +42.19% |
| GUBRA.CO | Gubra A/S | $1.03B | Small cap | +6.82% |
| QDEL | QuidelOrtho Corporation | $1.02B | Small cap | −46.31% |
| PCRX | Pacira BioSciences, Inc. | $1.02B | Small cap | −0.88% |
| CADL | Candel Therapeutics, Inc. | $1.02B | Small cap | +124.70% |
| GERN | Geron Corporation | $995.83M | Small cap | +8.51% |
| 7730.T | Mani, Inc. | $994.58M | Small cap | +31.25% |
| DSGN | Design Therapeutics, Inc. | $975.65M | Small cap | +194.71% |
| NEU.WA | NEUCA S.A. | $971.18M | Small cap | +22.80% |
| EUZ.DE | Eckert & Ziegler SE | $965.07M | Small cap | −22.81% |
| VETO.PA | Vetoquinol SA | $961.38M | Small cap | −6.46% |
| BVS | Bioventus Inc. | $954.22M | Small cap | +86.52% |
| OLMA | Olema Pharmaceuticals, Inc. | $949.35M | Small cap | +89.02% |
| 4521.T | Kaken Pharmaceutical Co., Ltd. | $947.00M | Small cap | +9.96% |
| ANNX | Annexon, Inc. | $946.00M | Small cap | +136.49% |
| DBVT | DBV Technologies S.A. | $940.80M | Small cap | +53.00% |
| XVIVO.ST | Xvivo Perfusion AB (publ) | $936.96M | Small cap | +68.75% |
| AMPH | Amphastar Pharmaceuticals, Inc. | $934.98M | Small cap | −27.78% |
| DBV.PA | DBV Technologies S.A. | $923.84M | Small cap | +56.64% |
| CLYM | Climb Bio Inc | $923.57M | Small cap | +603.72% |
| PHN.MI | Pharmanutra S.p.A. | $913.46M | Small cap | +70.81% |
| 3046.T | JINS HOLDINGS Inc. | $911.23M | Small cap | −23.78% |
| ACRS | Aclaris Therapeutics, Inc. | $911.16M | Small cap | +240.11% |
| B2RK34.SA | Bruker Corporation | $906.52M | Small cap | +63.27% |
| CBLL | CeriBell, Inc. | $899.97M | Small cap | +102.16% |
| 4587.T | PeptiDream Inc. | $898.07M | Small cap | −25.72% |
| SGP | SpyGlass Pharma, Inc. | $891.05M | Small cap | +0.91% |
| ANL | Adlai Nortye Ltd. | $884.83M | Small cap | +791.12% |
| TBPH | Theravance Biopharma, Inc. | $884.18M | Small cap | +23.41% |
| MCAP.ST | MedCap AB (publ) | $879.89M | Small cap | −9.69% |
| 7780.T | Menicon Co., Ltd. | $873.71M | Small cap | +58.71% |
| GNFT.PA | Genfit S.A. | $870.63M | Small cap | +327.25% |
| TALK | Talkspace, Inc. | $870.57M | Small cap | +93.73% |
| BBNX | Beta Bionics, Inc. | $870.10M | Small cap | +1.95% |
| AVR.AX | Anteris Technologies Global Corp. | $866.22M | Small cap | +120.54% |
| AVR | Anteris Technologies Global Corp. | $865.37M | Small cap | +144.54% |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +16.99% |
| INMD | InMode Ltd. | $864.89M | Small cap | −1.71% |
| SYNSAM.ST | Synsam AB (publ) | $864.35M | Small cap | +1.95% |
| SIBN | SI-BONE, Inc. | $861.71M | Small cap | +17.12% |
| OXB.L | Oxford Biomedica plc | $860.16M | Small cap | −6.01% |
| FDMT | 4D Molecular Therapeutics, Inc. | $859.60M | Small cap | +140.87% |
| 4694.T | BML, Inc. | $858.68M | Small cap | +6.14% |
| DYVOX.ST | Dynavox Group AB (publ) | $855.06M | Small cap | −38.08% |
| COLL | Collegium Pharmaceutical, Inc. | $852.79M | Small cap | −29.08% |
| ACHV | Achieve Life Sciences, Inc. | $851.00M | Small cap | +177.52% |
| AHG | Akso Health Group | $848.14M | Small cap | −43.10% |
| PHAR | Pharming Group N.V. | $845.80M | Small cap | −14.47% |
| APOTEA.ST | Apotea AB (publ) | $845.55M | Small cap | −24.60% |
| SLN | Silence Therapeutics plc | $840.94M | Small cap | +160.19% |
| HSTM | HealthStream, Inc. | $840.94M | Small cap | +1.86% |
| SFL.MI | Safilo Group S.p.A. | $839.99M | Small cap | +21.52% |
| AMS.L | Advanced Medical Solutions Group plc | $831.56M | Small cap | +39.03% |
| ESPR | Esperion Therapeutics, Inc. Common Stock | $819.46M | Small cap | +45.87% |
| NVCT | Nuvectis Pharma, Inc. | $816.10M | Small cap | +275.94% |
| WELL.TO | WELL Health Technologies Corp. | $807.72M | Small cap | −8.18% |
| 001067.KS | JW Pharmaceutical Corporation | $806.37M | Small cap | −23.44% |
| ARJO-B.ST | Arjo AB (publ) | $805.01M | Small cap | −15.46% |
| AURA | Aura Biosciences, Inc. | $801.64M | Small cap | +20.03% |
| STTK | Shattuck Labs, Inc. | $792.87M | Small cap | +690.00% |
| SNT.WA | Synektik Spólka Akcyjna | $772.46M | Small cap | +56.15% |
| AHCO | AdaptHealth Corp. | $771.43M | Small cap | −38.44% |
| NGNE | Neurogene Inc. | $768.64M | Small cap | +95.02% |
| MNPR | Monopar Therapeutics Inc. | $763.31M | Small cap | +226.69% |
| DRUG | Bright Minds Biosciences Inc. | $751.90M | Small cap | +76.73% |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $751.23M | Small cap | −0.43% |
| UU8.F | Neurogene Inc. | $748.28M | Small cap | +157.60% |
| EIQ.AX | Echo IQ Limited | $743.66M | Small cap | +564.29% |
| D2OC34.SA | Doximity, Inc. | $733.94M | Small cap | −65.76% |
| 4534.T | Mochida Pharmaceutical Co., Ltd. | $730.42M | Small cap | +8.26% |
| CTMX | CytomX Therapeutics, Inc. | $723.43M | Small cap | +60.39% |
| ASMB | Assembly Biosciences, Inc. | $721.17M | Small cap | +36.81% |
| OCS | Oculis Holding AG | $720.20M | Small cap | −25.14% |
| PHR | Phreesia, Inc. | $716.58M | Small cap | −63.74% |
| SSII | SS Innovations International, Inc. | $715.38M | Small cap | −50.55% |
| DHT-UN.TO | DRI Healthcare Trust | $714.70M | Small cap | +27.29% |
| XOMA | XOMA Royalty Corp | $710.16M | Small cap | +19.27% |
| PHAT | Phathom Pharmaceuticals, Inc. | $709.50M | Small cap | −29.50% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $708.88M | Small cap | +240.48% |
| 9267.T | Genky DrugStores Co., Ltd. | $707.77M | Small cap | −18.11% |
| GYRE | Gyre Therapeutics, Inc. | $705.12M | Small cap | −18.00% |
| ALLO | Allogene Therapeutics, Inc. | $704.80M | Small cap | +75.86% |
| C2RS34.SA | CRISPR Therapeutics AG | $704.10M | Small cap | +0.85% |
| EVT.DE | Evotec SE | $703.33M | Small cap | −43.20% |
| AGMB | AgomAb Therapeutics NV | $703.26M | Small cap | −2.53% |
| TECX | Tectonic Therapeutic, Inc. | $703.19M | Small cap | +35.43% |
| ZVRA | Zevra Therapeutics, Inc. | $697.17M | Small cap | +25.43% |
| 7575.T | Japan Lifeline Co., Ltd. | $696.48M | Small cap | +13.61% |
| PROK | ProKidney Corp. | $694.58M | Small cap | −30.12% |
| EVO | Evotec SE | $693.01M | Small cap | −44.13% |
| GMRS | GMR Solutions Inc. | $692.56M | Small cap | −8.30% |
| GUD.TO | Knight Therapeutics Inc. | $690.78M | Small cap | +50.39% |
| DHT-U.TO | DRI Healthcare Trust | $690.34M | Small cap | +27.68% |
| EIKN | Eikon Therapeutics, Inc. | $679.77M | Small cap | −20.13% |
| CU6.AX | Clarity Pharmaceuticals Ltd | $673.94M | Small cap | −15.77% |
| CBIO | Crescent Biopharma, Inc. | $669.39M | Small cap | +26.46% |
| 185750.KS | Chong Kun Dang Pharmaceutical Corp. | $657.93M | Small cap | −13.76% |
| CRMD | CorMedix Inc. | $653.95M | Small cap | −40.66% |
| LBIRD.PA | Lumibird SA | $650.27M | Small cap | +59.66% |
| PRME | Prime Medicine, Inc. | $649.33M | Small cap | +4.37% |
| ANGO | AngioDynamics, Inc. | $648.51M | Small cap | +56.74% |
| MDXG | MiMedx Group, Inc. | $644.26M | Small cap | −38.35% |
| 2HQ0.DE | Tilray Brands, Inc. | $643.43M | Small cap | −67.32% |
| 4565.T | Nxera Pharma Co., Ltd. | $642.58M | Small cap | +21.30% |
| VSTM | Verastem, Inc. | $641.19M | Small cap | −20.45% |
| TLRY.TO | Tilray Brands, Inc. | $640.36M | Small cap | +240.00% |
| CTNM | Contineum Therapeutics, Inc. | $640.31M | Small cap | +70.03% |
| KIDS | OrthoPediatrics Corp. | $639.69M | Small cap | +11.10% |
| TLRY | Tilray Brands, Inc. | $638.38M | Small cap | −66.13% |
| CTEV | Claritev Corporation | $636.72M | Small cap | −47.71% |
| VALN | Valneva SE | $634.84M | Small cap | −23.49% |
| 6197.T | Solasto Corporation | $634.50M | Small cap | +138.65% |
| CRW.L | Craneware plc | $633.59M | Small cap | −37.84% |
| DASA3.SA | Diagnósticos da América S.A. | $633.57M | Small cap | +93.33% |
| AYJ.DE | Valneva SE | $629.58M | Small cap | −26.20% |
| VLA.PA | Valneva SE | $629.58M | Small cap | −25.39% |
| AUTL | Autolus Therapeutics plc | $620.16M | Small cap | +48.41% |
| ARVN | Arvinas, Inc. | $609.40M | Small cap | +15.35% |
| ALT | Altimmune, Inc. | $604.95M | Small cap | −14.17% |
| IDX.AX | Integral Diagnostics Limited | $604.10M | Small cap | −21.62% |
| MPLT | MapLight Therapeutics, Inc. | $596.42M | Small cap | −29.88% |
| CTKB | Cytek Biosciences, Inc. | $594.02M | Small cap | +11.74% |
| 019175.KS | Shinpoong Pharmaceutical Co.,Ltd | $589.52M | Small cap | −31.70% |
| 3034.T | Qol Holdings Co., Ltd. | $588.82M | Small cap | +26.77% |
| EQS.PA | Equasens Société anonyme | $588.33M | Small cap | −26.89% |
| 005257.KS | GC Corp. | $588.29M | Small cap | −35.29% |
| RGNX | REGENXBIO Inc. | $588.18M | Small cap | +6.35% |
| RAY-B.ST | RaySearch Laboratories AB (publ) | $587.36M | Small cap | −26.61% |
| WEAV | Weave Communications, Inc. | $584.79M | Small cap | −5.68% |
| EOLS | Evolus, Inc. | $579.92M | Small cap | +15.83% |
| ARTV | Artiva Biotherapeutics, Inc. | $575.44M | Small cap | +259.94% |
| BWAY | BrainsWay Ltd. | $574.70M | Small cap | +87.42% |
| ZURA | Zura Bio Limited | $574.02M | Small cap | +177.31% |
| DCTH | Delcath Systems, Inc. | $569.06M | Small cap | +49.91% |
| SPRY | ARS Pharmaceuticals, Inc. | $568.84M | Small cap | −55.13% |
| 4559.T | Zeria Pharmaceutical Co., Ltd. | $563.59M | Small cap | +3.16% |
| OVID | Ovid Therapeutics Inc. | $562.46M | Small cap | +128.57% |
| AYA.AX | Artrya Limited | $559.36M | Small cap | +123.00% |
| 003850.KS | Boryung Corporation | $558.56M | Small cap | +10.58% |
| EVH | Evolent Health, Inc. | $556.25M | Small cap | −48.86% |
| ENTX | Entera Bio Ltd. | $552.32M | Small cap | +62.76% |
| CERS | Cerus Corporation | $552.18M | Small cap | +109.16% |
| 003090.KS | Daewoong Co., Ltd. | $551.27M | Small cap | −26.51% |
| 137310.KS | SD Biosensor, Inc. | $549.34M | Small cap | −35.54% |
| KYTX | Kyverna Therapeutics, Inc. | $546.70M | Small cap | +133.33% |
| FLGT | Fulgent Genetics, Inc. | $545.08M | Small cap | −8.46% |
| SRTA | Strata Critical Medical, Inc. | $541.42M | Small cap | +33.62% |
| TCMD | Tactile Systems Technology, Inc. | $532.56M | Small cap | +78.78% |
| J8J.F | TransThera Sciences (Nanjing), Inc. | $526.49M | Small cap | −90.30% |
| PRLD | Prelude Therapeutics Incorporated | $522.47M | Small cap | +412.50% |
| CCCC | C4 Therapeutics, Inc. | $521.63M | Small cap | +64.34% |
| 7979.T | Shofu Inc. | $520.84M | Small cap | +22.20% |
| BOI.PA | Boiron SA | $519.76M | Small cap | +21.80% |
| 2664.T | Cawachi Limited | $519.33M | Small cap | +36.71% |
| PNV.AX | PolyNovo Limited | $517.07M | Small cap | −21.67% |
| 4480.T | Medley, Inc. | $514.06M | Small cap | +9.35% |
| TOI | Starling Oncology Inc | $512.91M | Small cap | +79.19% |
| IMR.AX | Imricor Medical Systems, Inc. | $508.33M | Small cap | +40.21% |
| DNA | Ginkgo Bioworks Holdings, Inc. | $507.75M | Small cap | −41.46% |
| 4592.T | SanBio Company Limited | $504.78M | Small cap | −55.46% |
| NPCE | NeuroPace, Inc. | $503.88M | Small cap | +65.32% |
| 3151.T | Vital KSK Holdings, Inc. | $501.56M | Small cap | +40.36% |
| EVMN | Evommune, Inc. | $500.47M | Small cap | −30.25% |
| CLPT | ClearPoint Neuro, Inc. | $499.35M | Small cap | +53.85% |
| 317450.KS | MYUNGIN PHARM | $493.83M | Small cap | −55.33% |
| CGC | Canopy Growth Corporation | $492.21M | Small cap | −31.46% |
| 005690.KS | Pharmicell Co., Ltd. | $490.77M | Small cap | +1.06% |
| EPRX | Eupraxia Pharmaceuticals Inc. | $490.26M | Small cap | +40.72% |
| WEED.TO | Canopy Growth Corporation | $489.98M | Small cap | −31.25% |
| EDIT | Editas Medicine, Inc. | $488.38M | Small cap | +19.10% |
| EPRX.TO | Eupraxia Pharmaceuticals Inc. | $487.17M | Small cap | +43.78% |
| NRC | NRC Health | $487.06M | Small cap | +45.92% |
| RLMD | Relmada Therapeutics, Inc. | $485.35M | Small cap | +579.10% |
| RZLT | Rezolute, Inc. | $485.31M | Small cap | −30.00% |
| PACB | Pacific Biosciences of California, Inc. | $484.90M | Small cap | +17.29% |
| KMDA | Kamada Ltd. Ordinary Shares | $483.48M | Small cap | +21.09% |
| CAPR | Capricor Therapeutics, Inc. | $481.97M | Small cap | +49.76% |
| AGY.L | Allergy Therapeutics plc | $481.91M | Small cap | −28.66% |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | $481.69M | Small cap | −1.57% |
| QTTB | Q32 Bio Inc. | $481.67M | Small cap | +840.70% |
| CVX.PA | Carvolix SA | $478.45M | Small cap | +258.36% |
| OCGN | Ocugen, Inc. | $478.15M | Small cap | +35.58% |
| PRTA | Prothena Corporation plc | $474.87M | Small cap | +8.06% |
| 4549.T | Eiken Chemical Co., Ltd. | $474.80M | Small cap | −3.68% |
| PBYI | Puma Biotechnology, Inc. | $472.84M | Small cap | +79.61% |
| 001060.KS | JW Pharmaceutical Corporation | $461.26M | Small cap | +30.47% |
| ALVIO.PA | Valerio Therapeutics Société anonyme | $457.27M | Small cap | +1205.56% |
| BIOA | BioAge Labs, Inc. | $451.63M | Small cap | +107.59% |
| 000640.KS | Dong-A Socio Holdings Co., Ltd. | $450.37M | Small cap | −10.22% |
| BNTC | Benitec Biopharma Inc. | $442.48M | Small cap | +0.16% |
| AVIR | Atea Pharmaceuticals, Inc. | $441.93M | Small cap | +53.06% |
| AVCT.L | Avacta Group Plc | $439.28M | Small cap | +11.69% |
| CMPX | Compass Therapeutics, Inc. | $437.61M | Small cap | −25.91% |
| 001065.KS | JW Pharmaceutical Corporation | $435.33M | Small cap | −17.16% |
| LRMR | Larimar Therapeutics, Inc. | $432.15M | Small cap | +6.92% |
| FRX.TO | Fennec Pharmaceuticals Inc. | $429.52M | Small cap | +36.00% |
| FENC | Fennec Pharmaceuticals Inc. | $426.77M | Small cap | +34.62% |
| 4569.T | KYORIN Pharmaceutical Co., Ltd. | $423.78M | Small cap | −19.72% |
| LXEO | Lexeo Therapeutics, Inc. | $420.90M | Small cap | +3.30% |
| PRTC.L | PureTech Health plc | $420.70M | Small cap | +2.43% |
| GALT | Galectin Therapeutics Inc. | $418.53M | Small cap | +4.27% |
| CEVI.ST | CellaVision AB (publ) | $414.65M | Small cap | −2.59% |
| XFOR | X4 Pharmaceuticals, Inc. | $412.45M | Small cap | −1.42% |
| ENTA | Enanta Pharmaceuticals, Inc. | $412.12M | Small cap | +65.89% |
| LNA.PA | LNA Santé SA | $410.16M | Small cap | +12.87% |
| BLAU3.SA | Blau Farmacêutica S.A. | $406.91M | Small cap | −2.28% |
| 4552.T | JCR Pharmaceuticals Co., Ltd. | $406.58M | Small cap | −9.67% |
| 5889.T | JAPAN EYEWEAR HOLDINGS CO LTD | $404.37M | Small cap | +30.30% |
| M12.DE | M1 Kliniken AG | $402.47M | Small cap | +35.20% |
| FYB.DE | Formycon AG | $402.25M | Small cap | −17.60% |
| RCKT | Rocket Pharmaceuticals, Inc. | $401.78M | Small cap | +10.24% |
| FHTX | Foghorn Therapeutics Inc. | $397.29M | Small cap | +23.66% |
| OFIX | Orthofix Medical Inc. | $397.14M | Small cap | −34.30% |
| 019170.KS | Shinpoong Pharmaceutical Co.,Ltd | $394.97M | Small cap | −18.03% |
| IPSC | Century Therapeutics, Inc. | $392.93M | Small cap | +315.53% |
| NIOX.L | NIOX Group Plc | $392.29M | Small cap | −9.45% |
| UPB | Upstream Bio, Inc. | $390.52M | Small cap | −57.31% |
| TKNO | Alpha Teknova, Inc. | $387.63M | Small cap | +62.25% |
| MOBI | Mobia Medical, Inc. | $387.35M | Small cap | −0.85% |
| AUNA | Auna SA | $387.31M | Small cap | −16.85% |
| 4886.T | ASKA Pharmaceutical Holdings Co.,Ltd. | $377.48M | Small cap | −11.36% |
| 368A.T | KITAZATO CORPORATION | $376.06M | Small cap | +0.62% |
| ACL.AX | Australian Clinical Labs Limited | $375.86M | Small cap | +3.24% |
| VOX.WA | Voxel S.A. | $373.70M | Small cap | −19.51% |
| SLP | Simulations Plus, Inc. | $372.34M | Small cap | +28.20% |
| AGEN | Agenus Inc. | $371.33M | Small cap | +81.72% |
| PALI | Palisade Bio, Inc. | $371.20M | Small cap | +222.73% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $368.27M | Small cap | +113.74% |
| ALCLS.PA | Cellectis S.A. | $365.97M | Small cap | +32.31% |
| VHI.TO | Vitalhub Corp. | $364.45M | Small cap | −36.39% |
| N3B.F | Anbio Biotechnology | $364.31M | Small cap | −81.53% |
| LYEL | Lyell Immunopharma, Inc. | $362.68M | Small cap | +37.32% |
| 2395.T | Shin Nippon Biomedical Laboratories, Ltd. | $361.39M | Small cap | −15.15% |
| DMAC | DiaMedica Therapeutics Inc. | $361.30M | Small cap | +12.04% |
| CATX | Perspective Therapeutics, Inc. | $360.72M | Small cap | −12.47% |
| OPT.L | Optima Health plc | $359.15M | Small cap | +11.82% |
| 262A.T | INTERMESTIC INC | $357.38M | Small cap | −29.62% |
| 3733.T | Software Service, Inc. | $357.32M | Small cap | −14.02% |
| IFRX | InflaRx N.V. | $356.63M | Small cap | +142.00% |
| HUM.ST | Humana AB (publ) | $355.63M | Small cap | +80.96% |
| STRO | Sutro Biopharma, Inc. | $355.50M | Small cap | +138.11% |
| VMD | Viemed Healthcare, Inc. | $355.36M | Small cap | +29.94% |
| SABS | SAB Biotherapeutics, Inc. | $353.03M | Small cap | +83.02% |
| 377740.KS | BioNote, Inc. | $352.53M | Small cap | −11.98% |
| PNVL3.SA | Dimed S.A. Distribuidora de Medicamentos | $350.76M | Small cap | +20.56% |
| IKT | Inhibikase Therapeutics, Inc. | $347.44M | Small cap | +39.11% |
| CLLS | Cellectis S.A. | $344.40M | Small cap | +28.09% |
| ABEO | Abeona Therapeutics Inc. | $343.68M | Small cap | −12.90% |
| NNNN | Anbio Biotechnology | $343.67M | Small cap | −83.55% |
| OCA.AX | Oceania Healthcare Limited | $343.07M | Small cap | +9.17% |
| 197A.T | TAUNS LABORATORIES INC. | $340.37M | Small cap | −8.21% |
| 005250.KS | GC Corp. | $335.88M | Small cap | −31.59% |
| IMRX | Immuneering Corporation | $333.19M | Small cap | −0.77% |
| ILM1.DE | Medios AG | $333.05M | Small cap | −24.70% |
| P2OD34.SA | Insulet Corporation | $332.45M | Small cap | −26.20% |
| PRQR | ProQR Therapeutics N.V. | $331.63M | Small cap | +6.33% |
| 249420.KS | Ildong Pharmaceutical Co., Ltd. | $329.08M | Small cap | −41.30% |
| NP5.DE | Newron Pharmaceuticals S.p.A. | $325.96M | Small cap | +44.04% |
| VNDA | Vanda Pharmaceuticals Inc. | $323.48M | Small cap | +15.80% |
| MATD3.SA | Hospital Mater Dei S.A. | $321.33M | Small cap | +11.78% |
| IDHC.L | Integrated Diagnostics Holdings plc | $318.57M | Small cap | +18.05% |
| VICO.ST | Vicore Pharma Holding AB (publ) | $317.21M | Small cap | −7.55% |
| OBIO | Orchestra BioMed Holdings, Inc. | $316.15M | Small cap | +85.21% |
| IRD | Opus Genetics, Inc. | $316.14M | Small cap | +216.67% |
| RNAC | Cartesian Therapeutics, Inc. | $308.30M | Small cap | −4.09% |
| YDES | YD Bio Ltd | $307.41M | Small cap | −63.83% |
| CUV.AX | Clinuvel Pharmaceuticals Limited | $307.39M | Small cap | −20.09% |
| TMCI | Treace Medical Concepts, Inc. | $306.96M | Small cap | −36.39% |
| EBS | Emergent BioSolutions Inc. | $306.10M | Small cap | −30.50% |
| 7779.T | CYBERDYNE Inc. | $305.68M | Small cap | +16.00% |
| FATE | Fate Therapeutics, Inc. Common Stock | $305.54M | Small cap | +129.46% |
| BCYC | Bicycle Therapeutics plc | $304.03M | Small cap | −37.79% |
| TLSI | TriSalus Life Sciences, Inc. | $303.56M | Small cap | −3.33% |
| RAC.AX | Racura Oncology Ltd | $303.38M | Small cap | +86.61% |
| 003000.KS | Bukwang Pharmaceutical Co., Ltd. | $302.07M | Small cap | +30.64% |
| AMRN | Amarin Corporation plc | $301.43M | Small cap | −7.08% |
| AVXL | Anavex Life Sciences Corp. | $300.34M | Small cap | −65.71% |
| 4894.T | Cuorips Inc. | $300.07M | Small cap | −20.84% |
| 4554.T | Fuji Pharma Co., Ltd. | $299.59M | Small cap | +24.48% |
| MYGN | Myriad Genetics, Inc. | $298.43M | Small cap | −47.39% |
| TRDA | Entrada Therapeutics, Inc. | $296.70M | Small cap | +23.24% |
| BDSX | Biodesix, Inc. | $296.22M | Small cap | +225.53% |
| 7777.T | 3-D Matrix, Ltd. | $295.99M | Small cap | +68.69% |
| FULC | Fulcrum Therapeutics, Inc. | $294.51M | Small cap | −41.78% |
| NMRA | Neumora Therapeutics, Inc. | $293.12M | Small cap | −11.36% |
| 0120G0.KS | Samyang Biopharm | $292.45M | Small cap | +81.46% |
| TTRX | Turn Therapeutics Inc. | $292.44M | Small cap | +37.57% |
| CV | CapsoVision, Inc. | $291.27M | Small cap | +46.97% |
| ANIK | Anika Therapeutics, Inc. | $290.14M | Small cap | +136.17% |
| EDT.TO | Spectral Medical Inc. | $286.47M | Small cap | −6.99% |
| EMBC | Embecta Corp. | $285.00M | Small cap | −64.70% |
| LCTX | Lineage Cell Therapeutics, Inc. | $283.26M | Small cap | −8.20% |
| PIHLIS.HE | Pihlajalinna Oyj | $281.87M | Small cap | −31.45% |
| 950210.KS | Prestige BioPharma Limited | $281.68M | Small cap | −53.07% |
| PYXS | Pyxis Oncology, Inc. | $278.58M | Small cap | +145.59% |
| WHWK | Whitehawk Therapeutics, Inc. | $275.92M | Small cap | +167.40% |
| AFP.AX | AFT Pharmaceuticals Limited | $275.47M | Small cap | +65.91% |
| SRZN | Surrozen, Inc. | $274.56M | Small cap | +107.98% |
| ALXO | ALX Oncology Holdings Inc. | $273.79M | Small cap | +65.00% |
| TSTL.L | Tristel plc | $272.71M | Small cap | +15.66% |
| ELDN | Eledon Pharmaceuticals, Inc. | $272.22M | Small cap | +29.84% |
| CGEN | Compugen Ltd. | $271.86M | Small cap | +93.20% |
| 170900.KS | Dong-A ST Co., Ltd. | $268.89M | Small cap | −7.92% |
| GLSI | Greenwich LifeSciences, Inc. | $267.58M | Small cap | +56.21% |
| IVVD | Invivyd, Inc. | $265.78M | Small cap | +3.52% |
| RXST | RxSight, Inc. | $265.36M | Small cap | −25.38% |
| TTX.AX | Tetratherix Limited | $264.62M | Small cap | +66.19% |
| CAMP | CAMP4 THERAPEUTICS CORPORATION | $263.56M | Small cap | +178.15% |
| ALEC | Alector, Inc. | $263.51M | Small cap | +2.50% |
| TNG.PA | Transgene SA | $261.89M | Small cap | −29.21% |
| 4820.T | EM Systems Co., Ltd. | $261.36M | Small cap | −18.04% |
| PRN.TO | Profound Medical Corp. | $260.59M | Small cap | +59.16% |
| NAGE | Niagen Bioscience, Inc. | $260.44M | Small cap | −66.22% |
| SLGL | Sol-Gel Technologies Ltd. | $260.05M | Small cap | +261.87% |
| PROF | Profound Medical Corp. | $259.75M | Small cap | +57.30% |
| NERV | Minerva Neurosciences, Inc. | $259.27M | Small cap | +129.11% |
| 7749.T | Medikit Co.,Ltd. | $259.07M | Small cap | +18.63% |
| 4593.T | Healios K.K. | $258.92M | Small cap | −43.33% |
| ADAG | Adagene Inc. | $258.50M | Small cap | +75.80% |
| CPH.TO | Cipher Pharmaceuticals Inc. | $258.19M | Small cap | −7.84% |
| MGNX | MacroGenics, Inc. Common Stock | $257.35M | Small cap | +134.88% |
| 7071.T | Amvis Holdings, Inc. | $256.41M | Small cap | −34.00% |
| OFSA3.SA | Ouro Fino Saúde Animal Participações S.A. | $256.27M | Small cap | +18.69% |
| 6823.T | Rion Co., Ltd. | $256.19M | Small cap | +30.77% |
| OSUR | OraSure Technologies, Inc. | $255.87M | Small cap | +11.08% |
| R2AR34.SA | Ultragenyx Pharmaceutical Inc. | $255.25M | Small cap | +11.74% |
| LAB | Standard BioTools Inc. | $255.18M | Small cap | −49.08% |
| IPHA | Innate Pharma S.A. | $253.56M | Small cap | +2.86% |
| ALMDT.PA | Median Technologies SA | $253.19M | Small cap | +79.07% |
| AKBA | Akebia Therapeutics, Inc. | $251.20M | Small cap | −69.88% |
| 4548.T | Seikagaku Corporation | $247.39M | Small cap | +12.98% |
| SPL.AX | Starpharma Holdings Limited | $245.48M | Small cap | +472.00% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.